February 28, 2013
Ethicon subsidiary maintains device failure was within standard risk of complications.
Move follows company's split into two different firms.
The agency will be accepting input until May 10.
New member is chairman and CEO of Conceptus.
The extended lengths will benefit heart patients with diabetes.
Allergan will be required to perform long-term post-op studies to ensure safety.
Facility expansion caps 8,500 square feet.
Money will fund U.S. trial for renal device.
Executive brings three decades of medical device experience.
A declining trend was reversed in 2011, and with MDUFA only promises to get better.
Second Sight Medical Products provides hope for those with retinitis pigmentosa.
Latest expansion is part of a global growth strategy.
COO will retain his previous responsibilities of senior VP and CFO.
Xagenic will receive approximately $1 million in this round of financing.
New appointee brings academic and industry experience to the table.
Deal gives Cardinal access to home healthcare market.
Company reports positive results from two-year study.
Platform combines TissueGen's knowledge in drug delivery with BMS' textiles experience.
Facility enhances firm's biomaterials R&D offerings.
Concerns over fracture of wire prompts latest high-risk recall effort.
U.S. Supreme Court refuses to hear Gore appeal.
Firm allegedly imported unlicensed products into country.
Executive has extensive financial background.
BMS CEO remains, MPC CEO to become chief tech officer.
AdvaMed cries foul.
Supporters try to build more momentum within a new session of Congress.
The unit opens door to neurodiagnostic research market for Natus.
Acquisition comes shortly after executive shuffle.
Company appoints cardiac CEO as replacement for outgoing member.
New line offers longer battery life of up to a decade.
Director has extensive Indiana state legislative experience.
Please visit our sister sites:
The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.